SENASA tightens controls and demands 100% efficacy from bovine anti-sarcoptic agents

With the aim of strengthening animal health and optimizing the records of veterinary products in livestock production, the SENASA has updated the evaluation and control processes of medications intended to combat bovine mange. The measure was made official through Resolution 865/2025, published in the Official Bulletin. Rigorous protocols and scientific control The new regulation establishes the specific processes and requirements for conducting official clinical safety and efficacy tests of bovine anti-mange products. A central element of the resolution is the creation of a specialized Technical Commission, whose intervention will ensure the scientific validity of the studies implemented. For official approval, the anti-mange products submitted for control must achieve 100% efficacy. Once this standard is approved, the certificate of use and commercialization of the product will have a validity of 10 years. The Technical Commission, responsible for executing the test, will have ...